Inactivation of the carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: A study using genetically encoded FRET-based reporters

Human Molecular Genetics

Volumn 23, Issue 5, 2014, Pages 1163-1174

  Cazabat, Laure ^a,b   Ragazzon, Bruno ^a,b   Varin, Audrey ^c,d   Potier cartereau, Marie ^e,f   Vandier, Christophe ^e,f   Vezzosi, Delphine ^a,b   Risk rabin, Marthe ^a   Guellich, Aziz ^c,d   Schittl, Julia ^c,d   Lechêne, Patrick ^c,d   Richter, Wito ^g   Nikolaev, Viacheslav O ^h   Zhang, Jin ⁱ   Bertherat, Jérôme ^a,b,j   Vandecasteele, Grégoire ^c,d  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Universite Paris Sud   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e CHRU de Tours   (France)

^f UNIVERSITÉ DE TOURS   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j The Johns Hopkins University School of Medicine ^*  (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPROSTADIL; CARNEY COMPLEX; CELL MEMBRANE; COLFORSIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; GENE SILENCING; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; PROTEIN TRANSPORT; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84894025718     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt510     Document Type: Article

References (68)

1. Tasken, K. and Aandahl, E.M. (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev., 84, 137-167.
2. Corbin, J.D., Keely, S.L. and Park, C.R. (1975) The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues. J. Biol. Chem., 250, 218-225.
3. Reimann, E.M., Walsh, D.A. and Krebs, E.G. (1971) Purification and properties of rabbit skeletal muscle adenosine 3 ' ,5 ' -monophosphatedependent protein kinases. J. Biol. Chem., 246, 1986-1995.
4. Dostmann, W.R., Taylor, S.S., Genieser, H.G., Jastorff, B., Doskeland, S.O. and Ogreid, D. (1990) Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J. Biol. Chem., 265, 10484-10491.
5. Amieux, P.S. and McKnight, G.S. (2002) The essential role of RI alpha in the maintenance of regulated PKA activity. Ann. N. Y. Acad. Sci., 968, 75-95.
6. Uhler, M.D. and McKnight, G.S. (1987) Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. J. Biol. Chem., 262, 15202-15207.
7. Mantovani, G., Lania, A.G., Bondioni, S., Peverelli, E., Pedroni, C., Ferrero, S., Pellegrini, C., Vicentini, L., Arnaldi, G., Bosari, S. et al. (2008) Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation. Exp. Cell. Res., 314, 123-130.
8. Amieux, P.S., Howe, D.G., Knickerbocker, H., Lee, D.C., Su, T., Laszlo, G.S., Idzerda, R.L. and McKnight, G.S. (2002) Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J. Biol. Chem., 277, 27294-27304.
9. Yin, Z., Jones, G.N., Towns, W.H. 2nd, Zhang, X., Abel, E.D., Binkley, P.F., Jarjoura, D. and Kirschner, L.S. (2008) Heart-specific ablation of prkar1a causes failure of heart development and myxomagenesis. Circulation, 117, 1414-1422.
10. Scott, J.D., Dessauer, C.W. and Tasken, K. (2013) Creating order from chaos: cellular regulation by kinase anchoring. Annu. Rev. Pharmacol. Toxicol., 53, 187-210.
11. Coghlan, V.M., Perrino, B.A., Howard, M., Langeberg, L.K., Hicks, J.B., Gallatin, W.M. and Scott, J.D. (1995) Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science, 267, 108-111.
12. Marx, S.O., Kurokawa, J., Reiken, S., Motoike, H., D'Armiento, J., Marks, A.R. and Kass, R.S. (2002) Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science, 295, 496-499.
13. Dodge, K.L., Khouangsathiene, S., Kapiloff, M.S., Mouton, R., Hill, E.V., Houslay, M.D., Langeberg, L.K. and Scott, J.D. (2001) mAKAPassembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J., 20, 1921-1930.
14. Tasken, K.A., Collas, P., Kemmner, W.A., Witczak, O., Conti, M. and Tasken, K. (2001) Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. J. Biol. Chem., 276, 21999-22002.
15. Willoughby, D., Wong, W., Schaack, J., Scott, J.D. and Cooper, D.M. (2006) An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J., 25, 2051-2061.
16. Ruppelt, A., Mosenden, R., Gronholm, M., Aandahl, E.M., Tobin, D., Carlson, C.R., Abrahamsen, H., Herberg, F.W., Carpen, O. and Tasken, K. (2007) Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. J. Immunol., 179, 5159-5168.
17. Lim, C.J., Han, J., Yousefi, N., Ma, Y., Amieux, P.S., McKnight, G.S., Taylor, S.S. and Ginsberg, M.H. (2007) Alpha4 integrins are Type I cAMP-dependent protein kinase-anchoring proteins. Nat. Cell. Biol., 9, 415-421.
18. Di Benedetto, G., Zoccarato, A., Lissandron, V., Terrin, A., Li, X., Houslay, M.D., Baillie, G.S. and Zaccolo, M. (2008) Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ. Res., 103, 836-844.
19. Means, C.K., Lygren, B., Langeberg, L.K., Jain, A., Dixon, R.E., Vega, A.L., Gold, M.G., Petrosyan, S., Taylor, S.S., Murphy, A.N. et al. (2011) An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria. Proc. Natl. Acad. Sci. USA, 108, E1227-E1235.
20. Pidoux, G., Witczak, O., Jarnaess, E., Myrvold, L., Urlaub, H., Stokka, A.J., Kuntziger, T. and Tasken, K. (2011) Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis. EMBO J., 30, 4371-4386.
21. Burgers, P.P., Ma, Y., Margarucci, L., Mackey, M., van der Heyden, M.A., Ellisman, M., Scholten, A., Taylor, S.S. and Heck, A.J. (2012) Asmall novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane. J. Biol. Chem., 287, 43789-43797.
22. Li, H., Degenhardt, B., Tobin, D., Yao, Z.X., Tasken, K. and Papadopoulos, V. (2001) Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein. Mol. Endocrinol., 15, 2211-2228.
23. Carlson, C.R., Lygren, B., Berge, T., Hoshi, N., Wong, W., Tasken, K. and Scott, J.D. (2006) Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J. Biol. Chem., 281, 21535-21545.
24. Linglart, A., Menguy, C., Couvineau, A., Auzan, C., Gunes, Y., Cancel, M., Motte, E., Pinto, G., Chanson, P., Bougneres, P. et al. (2011) Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N. Engl. J. Med., 364, 2218-2226.
25. Nagasaki, K., Iida, T., Sato, H., Ogawa, Y., Kikuchi, T., Saitoh, A., Ogata, T. and Fukami, M. (2012) PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance. J. Clin. Endocrinol. Metab., 97, E1808-E1813.
26. Linglart, A., Fryssira, H., Hiort, O., Holterhus, P.M., Perez de Nanclares, G., Argente, J., Heinrichs, C., Kuechler, A., Mantovani, G., Leheup, B. et al. (2012) PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance. J. Clin. Endocrinol. Metab., 97, E2328-E2338.
27. Casey, M., Vaughan, C.J., He, J., Hatcher, C.J., Winter, J.M., Weremowicz, S.,Montgomery, K., Kucherlapati, R., Morton, C.C. and Basson, C.T. (2000) Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J. Clin. Invest., 106, R31-R38.
28. Kirschner, L.S., Carney, J.A., Pack, S.D., Taymans, S.E., Giatzakis, C., Cho, Y.S., Cho-Chung, Y.S. and Stratakis, C.A. (2000) Mutations of the gene encoding the protein kinaseAtype I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet., 26, 89-92.
29. Groussin, L., Kirschner, L.S., Vincent-Dejean, C., Perlemoine, K., Jullian, E., Delemer, B., Zacharieva, S., Pignatelli, D., Carney, J.A., Luton, J.P. et al. (2002) Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am. J. Hum. Genet., 71, 1433-1442.
30. Bertherat, J. (2006) Carney complex (CNC). Orphanet J. Rare Dis., 1, 21.
31. Carney, J.A., Gordon, H., Carpenter, P.C., Shenoy, B.V. and Go, V.L. (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore), 64, 270-283.
32. Horvath, A., Bertherat, J., Groussin, L., Guillaud-Bataille, M., Tsang, K., Cazabat, L., Libe, R., Remmers, E., Rene-Corail, F., Faucz, F.R. et al. (2010) Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum. Mutat., 31, 369-379.
33. Robinson-White, A., Hundley, T.R., Shiferaw, M., Bertherat, J., Sandrini, F. and Stratakis, C.A. (2003) Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum. Mol. Genet., 12, 1475-1484.
34. Nadella, K.S. and Kirschner, L.S. (2005) Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res., 65, 10307-10315.
35. Veugelers, M., Wilkes, D., Burton, K., McDermott, D.A., Song, Y., Goldstein, M.M., La Perle, K., Vaughan, C.J., O'Hagan, A., Bennett, K.R. et al. (2004) Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc. Natl. Acad. Sci. USA, 101, 14222-14227.
36. Burton, K.A., McDermott, D.A., Wilkes, D., Poulsen, M.N., Nolan, M.A., Goldstein, M., Basson, C.T. and McKnight, G.S. (2006) Haploinsufficiency at the protein kinase A RI alpha gene locus leads to fertility defects in male mice and men. Mol. Endocrinol., 20, 2504-2513.
37. Sahut-Barnola, I., de Joussineau, C., Val, P., Lambert-Langlais, S., Damon, C., Lefrancois-Martinez, A.M., Pointud, J.C., Marceau, G., Sapin, V., Tissier, F. et al. (2010) Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet., 6, e1000980.
38. Beavo, J.A., Bechtel, P.J. and Krebs, E.G. (1974) Activation of protein kinase by physiological concentrations of cyclicAMP.Proc. Natl. Acad. Sci. USA, 71, 3580-3583.
39. Corbin, J.D., Sugden, P.H., Lincoln, T.M. and Keely, S.L. (1977) Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue. J. Biol. Chem., 252, 3854-3861.
40. Saucerman, J.J., Zhang, J., Martin, J.C., Peng, L.X., Stenbit, A.E., Tsien, R.Y. and McCulloch, A.D. (2006) Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes. Proc. Natl. Acad. Sci. USA, 103, 12923-12928.
41. Allen, M.D. and Zhang, J. (2006) Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem. Biophys. Res. Commun., 348, 716-721.
42. Nikolaev, V.O., Bunemann, M., Hein, L., Hannawacker, A. and Lohse, M.J. (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J. Biol. Chem., 279, 37215-37218.
43. DiPilato, L.M., Cheng, X. and Zhang, J. (2004) Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc. Natl. Acad. Sci. USA, 101, 16513-16518.
44. Ponsioen, B., Zhao, J., Riedl, J., Zwartkruis, F., van der Krogt, G., Zaccolo, M., Moolenaar, W.H., Bos, J.L. and Jalink, K. (2004) Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep., 5, 1176-1180.
45. Terrin, A., Di Benedetto, G., Pertegato, V., Cheung, Y.F., Baillie, G., Lynch, M.J., Elvassore, N., Prinz, A., Herberg, F.W., Houslay, M.D. et al. (2006) PGE(1) stimulation ofHEK293cells generates multiple contiguous domains with different cAMP: role of compartmentalized phosphodiesterases. J. Cell. Biol., 175, 441-451.
46. Willoughby, D., Baillie, G.S., Lynch, M.J., Ciruela, A., Houslay, M.D. and Cooper, D.M. (2007) Dynamic regulation, desensitization, and cross-talk in discrete subcellular microdomains during beta2-adrenoceptor and prostanoid receptor cAMP signaling. J. Biol. Chem., 282, 34235-34249.
47. Jefcoate, C. (2002) High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex. J. Clin. Invest., 110, 881-890.
48. Smolenski, A., Bachmann, C., Reinhard, K., Honig-Liedl, P., Jarchau, T., Hoschuetzky, H. and Walter, U. (1998) Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J. Biol. Chem., 273, 20029-20035.
49. Reinhard, M., Halbrugge, M., Scheer, U., Wiegand, C., Jockusch, B.M. and Walter, U. (1992) The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J., 11, 2063-2070.
50. Zacharias, D.A., Violin, J.D., Newton, A.C. and Tsien, R.Y. (2002) Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science, 296, 913-916.
51. Ragazzon, B., Cazabat, L., Rizk-Rabin, M., Assie, G., Groussin, L., Fierrard, H., Perlemoine, K., Martinez, A. and Bertherat, J. (2009) Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells. Cancer Res., 69, 7278-7284.
52. Griffin, K.J., Kirschner, L.S., Matyakhina, L., Stergiopoulos, S., Robinson-White, A., Lenherr, S., Weinberg, F.D., Claflin, E., Meoli, E., Cho-Chung, Y.S. et al. (2004) Down-regulation of regulatory subunit type 1A of protein kinaseAleads to endocrine and other tumors. Cancer Res., 64, 8811-8815.
53. Griffin, K.J., Kirschner, L.S., Matyakhina, L., Stergiopoulos, S.G., Robinson-White, A., Lenherr, S.M., Weinberg, F.D., Claflin, E.S., Batista, D., Bourdeau, I. et al. (2004) A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J. Med. Genet., 41, 923-931.
54. Robinson-White, A., Meoli, E., Stergiopoulos, S., Horvath, A., Boikos, S., Bossis, I. and Stratakis, C.A. (2006) PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J. Clin. Endocrinol. Metab., 91, 2380-2388.
55. Robinson-White, A.J., Leitner, W.W., Aleem, E., Kaldis, P., Bossis, I. and Stratakis, C.A. (2006) PRKAR1A inactivation leads to increased proliferation and decreased apoptosis inhumanBlymphocytes. Cancer Res., 66, 10603-10612.
56. Rich, T.C., Fagan, K.A., Tse, T.E., Schaack, J., Cooper, D.M. and Karpen, J.W. (2001) Auniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc. Natl. Acad. Sci. USA, 98, 13049-13054.
57. Rich, T.C., Xin, W., Mehats, C., Hassell, K.A., Piggott, L.A., Le, X., Karpen, J.W. and Conti, M. (2007) Cellular mechanisms underlying prostaglandin-induced transientcAMPsignals near the plasma membrane of HEK-293 cells. Am. J. Physiol. Cell. Physiol., 292, C319-C331.
58. Nikolaev, V.O., Moshkov, A., Lyon, A.R., Miragoli, M., Novak, P., Paur, H., Lohse, M.J., Korchev, Y.E., Harding, S.E. and Gorelik, J. (2010) Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science, 327, 1653-1657.
59. Tsang, K.M., Starost, M.F., Nesterova, M., Boikos, S.A., Watkins, T., Almeida, M.Q., Harran, M., Li, A., Collins, M.T., Cheadle, C. et al. (2010) Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone. Proc. Natl. Acad. Sci. USA, 107, 8683-8688.
60. Almeida, M.Q., Tsang, K.M., Cheadle, C., Watkins, T., Grivel, J.C., Nesterova, M., Goldbach-Mansky, R. and Stratakis, C.A. (2011) Protein kinaseAregulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors. Hum. Mol. Genet., 20, 165-175.
61. Blackman, B.E., Horner, K., Heidmann, J., Wang, D., Richter, W., Rich, T.C. and Conti, M. (2011) PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts. J. Biol. Chem., 286, 12590-12601.
62. Xie, M., Rich, T.C., Scheitrum, C., Conti, M. and Richter, W. (2011) Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP. Mol. Pharmacol., 80, 281-293.
63. Gangal, M., Clifford, T., Deich, J., Cheng, X., Taylor, S.S. and Johnson, D.A. (1999) Mobilization of the A-kinase N-myristate through an isoform-specific intermolecular switch. Proc. Natl. Acad. Sci. USA, 96, 12394-12399.
64. Gaffarogullari, E.C., Masterson, L.R., Metcalfe, E.E., Traaseth, N.J., Balatri, E., Musa, M.M., Mullen, D., Distefano, M.D. and Veglia, G. (2011) Amyristoyl/phosphoserine switch controls cAMP-dependent protein kinase association to membranes. J. Mol. Biol., 411, 823-836.
65. Groussin, L., Jullian, E., Perlemoine, K., Louvel, A., Leheup, B., Luton, J.P., Bertagna, X. and Bertherat, J. (2002) Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J. Clin. Endocrinol. Metab., 87, 4324-4329.
66. Groussin, L., Horvath, A., Jullian, E., Boikos, S., Rene-Corail, F., Lefebvre, H., Cephise-Velayoudom, F.L., Vantyghem, M.C., Chanson, P., Conte-Devolx, B. et al. (2006) A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J. Clin. Endocrinol. Metab., 91, 1943-1949.
67. Ma, Y. and Taylor, S.S. (2008) A molecular switch for targeting between endoplasmic reticulum (ER) and mitochondria: conversion of a mitochondria-targeting element into an ER-targeting signal in DAKAP1. J. Biol. Chem., 283, 11743-11751.
68. Bolte, S. and Cordelieres, F.P. (2006) A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc., 224, 213-232.